Skip to main content

ORIGINAL RESEARCH article

Front. Psychiatry

Sec. Neurostimulation

Volume 16 - 2025 | doi: 10.3389/fpsyt.2025.1494811

This article is part of the Research Topic Treatment Resistant Depression (TRD): epidemiology, clinic, burden and treatment View all 22 articles

Effect of TMS Laterality on Clinical Outcomes in Treatment Resistant Depression patients with Comorbid Anxiety -A Retrospective Study

Provisionally accepted
  • 1 Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, United States
  • 2 Morsani College of Medicine, USF Health, Tampa, Florida, United States
  • 3 National Institute of Mental Health (NIH), Bethesda, Maryland, United States

The final, formatted version of the article will be published soon.

    Objectives: High-frequency repetitive transcranial magnetic stimulation (rTMS) of the left-hemisphere dorsolateral prefrontal cortex (DLPFC) is FDA cleared for the treatment of adult treatment-resistant major depressive disorder (MDD). Though off-label, sequential bilateral stimulation (SBS), which combines high-frequency left-hemisphere and low-frequency right-hemisphere DLPFC stimulation, is offered in various clinics to treat depression with comorbid anxiety. Few systematic studies investigate the comparative efficacy of the SBS protocol versus the FDA-label protocol for the clinical management of depression with comorbid anxiety. The objective of the current study was to compare the efficacy of HF-LUS to that of SBS within a clinical setting where both are offered to patients with anxious depression. Based on both theories of the pathophysiology of anxious depression as well as clinical practice, we hypothesized that SBS would result in greater symptom reduction as compared to HF-LUS.Methods: This open label, retrospective cohort study included 86 patients with MDD and comorbid anxiety who received either high frequency left unilateral stimulation (HF-LUS) (n=44) or SBS (n=42). Patient Health Questionnaire 9 (PHQ9), General Anxiety Disorder 7 (GAD7) questionnaire, a self-reported depression (SRD) Likert scale, and a self-reported anxiety (SRA) Likert scale were used to quantify changes in depressive and anxiety symptoms.Results: Inconsistent with our hypothesis, both groups saw a significant improvement in depression and anxiety symptoms with no difference in course nor degree of improvement. Improvements in depression and anxiety were significantly positively correlated in both bilateral and unilateral cohorts.Conclusions: Bilateral rTMS may not provide any additional therapeutic advantages over the standard FDA-cleared left unilateral rTMS protocol for anxious depressive patients.

    Keywords: repetitive transcranial magnetic stimulation, Anxious depression, dorsolateral prefrontal cortex, unilateral, bilateral

    Received: 11 Sep 2024; Accepted: 04 Mar 2025.

    Copyright: © 2025 Caussat, Blair and Oberman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Thomas Caussat, Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, United States
    Lindsay Oberman, National Institute of Mental Health (NIH), Bethesda, 20892-9663, Maryland, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more